As Vice President, Clinical Development Operations at Marengo Therapeutics, Katie has 20 years of industry experience in the biotech and pharmaceutical industry with a particular focus in conducting oncology clinical trials. She has been responsible for leading and delivering on trial execution to gain regulatory approvals, along with global regulatory inspection experience. Katie was recently at Servier, overseeing an oncology portfolio and managing several programs in various stages of clinical development from the early to late phases to post-marketing. During her tenure at Servier, she was responsible for conducting pivotal studies in both hematologic and solid tumor malignancies with successful regulatory submissions and approvals. Prior to Servier, Katie was at Agios Pharmaceuticals as well as Ariad Pharmaceuticals, where she managed clinical oncology trials, which resulted in regulatory approvals in various indications.

Katie has a bachelor’s degree in psychology and a master’s degree of science in clinical research from the Massachusetts College of Pharmacy and Health Sciences, where she currently serves as an advisor and an ad hoc guest speaker.